Cellectar Biosciences

(NASDAQ) CLRB

Current Price$2.59

Market Cap$20.14M

Since IPO (2011)-100%

5 Year-99%

1 Year-66%

1 Month-20%

Cellectar Biosciences Financials at a Glance

Market Cap

$20.14M

Revenue (TTM)

$0.00

Net Income (TTM)

-$20.84M

EPS (TTM)

-$7.37

P/E Ratio

-0.34

Dividend

$0.00

Beta (Volatility)

1.09 (Average)

Dividend

$0.00

Beta (Volatility)

1.09 (Average)

Price

$2.59

Volume

184,423

Open

$2.58

Price

$2.59

Volume

184,423

Open

$2.58

Previous Close

$2.60

Daily Range

$2.52 - $2.70

52-Week Range

$2.20 - $8.05

Estimated Earnings Date

Aug 13, 2026

Dividend

$0.00

Beta (Volatility)

1.09 (Average)

Price

$2.59

Volume

184,423

Open

$2.58

Previous Close

$2.60

Daily Range

$2.52 - $2.70

52-Week Range

$2.20 - $8.05

Estimated Earnings Date

Aug 13, 2026

CLRB News

Cellectar Cuts Q2 Losses and Expenses

Motley Fool Markets TeamAug 14, 2025

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cellectar Biosciences

Industry

Biotechnology

Sector

Health Care

Employees

CEO

James V. Caruso

Website

www.cellectar.com

Headquarters

Florham Park, NJ 07932, US

CLRB Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

-264.79%

Return on Capital

-222.48%

Return on Assets

-187.42%

Earnings Yield

-2.94%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$20.14M

Shares Outstanding

7.99M

Volume

184.42K

Avg. Volume

1.03M

Financials (TTM)

Gross Profit

$110.02K

Operating Income

-$22.37M

EBITDA

-$20.79M

Operating Cash Flow

-$18.58M

Capital Expenditure

-$9.26K

Free Cash Flow

-$18.59M

Cash & ST Invst.

$8.35M

Total Debt

$1.53M

Cellectar Biosciences Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$110.02K

N/A

Gross Margin

0.00%

N/A

Market Cap

$20.14M

N/A

Market Cap/Employee

$1.83M

N/A

Employees

N/A

Net Income

-$5.65M

+14.4%

EBITDA

-$5.76M

+12.0%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$8.35M

-40.0%

Total Debt

$1.53M

+222.3%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$1.53M

+295.9%

Short Term Debt

$0.00

-100.0%

Return on Assets

-1.87%

N/A

Return on Invested Capital

-3.58%

N/A

Free Cash Flow

-$4.85M

+48.3%

Operating Cash Flow

-$4.85M

+48.4%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

SNSESensei Biotherapeutics, Inc.

SNSESensei Biotherapeutics, Inc.$13.85-22.28%

MRKRMarker Therapeutics, Inc.

MRKRMarker Therapeutics, Inc.$1.46+11.03%

CINGCingulate Inc.

CINGCingulate Inc.$5.32+7.26%

BOLTBolt Biotherapeutics, Inc.

BOLTBolt Biotherapeutics, Inc.$3.91-8.66%

MBIOMustang Bio, Inc.

MBIOMustang Bio, Inc.$0.70-0.53%

RNAZTransCode Therapeutics, Inc.

RNAZTransCode Therapeutics, Inc.$5.24+5.43%

IMNNImunon, Inc.

IMNNImunon, Inc.$1.80+0.56%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

CMCSAComcast

CMCSAComcast$24.22+0.05%

AALAmerican Airlines Group

AALAmerican Airlines Group$17.92+0.00%

NOKNokia

NOKNokia$13.03+0.00%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.64+0.17%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$77.19+0.07%

SOFISoFi Technologies

SOFISoFi Technologies$18.19+0.02%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$38.16-0.08%

Questions About CLRB

What is the current price of Cellectar Biosciences?

Cellectar Biosciences is trading at $2.60 per share.

What is the 52-week range for Cellectar Biosciences?

Over the past 52 weeks, Cellectar Biosciences has traded between $2.20 and $8.05.

How much debt does Cellectar Biosciences have?

As of the most recent reporting period, Cellectar Biosciences reported total debt of $1.53M.

How much cash does Cellectar Biosciences have on hand?

Cellectar Biosciences reported $8.35M in cash and cash equivalents in its most recent financial results.

What is Cellectar Biosciences’s dividend yield?

Cellectar Biosciences does not currently have a dividend yield.

Cellectar Biosciences

Cellectar Biosciences Financials at a Glance

CLRB News

Cellectar Cuts Q2 Losses and Expenses

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Cellectar Biosciences

CLRB Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Cellectar Biosciences Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About CLRB

What is the current price of Cellectar Biosciences?

What is the 52-week range for Cellectar Biosciences?

How much debt does Cellectar Biosciences have?

How much cash does Cellectar Biosciences have on hand?

What is Cellectar Biosciences’s dividend yield?

Premium Investing Services